You searched for "surgeons"
ENTelligence: driving safe and transparent AI innovation in ENT
AI is seemingly going to be ubiquitous. How do we as ENT clinicians help to shape its direction? Artificial Intelligence (AI) is reshaping modern medicine. Algorithmic analysis is now influencing decisions once made solely by clinicians. Yet, in surgical specialties...
Can SNOT-22 predict the need for surgery?
In this prospective Belgian study, the authors looked at whether the baseline Sino-Nasal Outcome Test-22 (SNOT-22) was able to predict the need for surgery and localise the pathology of rhinology patients and healthy volunteers. A total of 66 healthy volunteers...From the editor March/April 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Changes are afoot here at ENT & Audiology News, so loyal readers will notice a few differences for March/April...ENT in this issue...Rhinoplasty
Joanne Rimmer, MBBS, MA(Hons)Cantab, FRCS(ORL‑HNS), Consultant Otolaryngologist / Rhinologist, Monash Health, Melbourne, Australia. E: rimmer.joanne@gmail.com Rhinoplasty may be done purely for aesthetic reasons, as an essential part of a functional septorhinoplasty, or for a combination of both cosmetic and functional...ENT in this issue...BACO 2023
Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net BACO (the British Academic Conference of Otolaryngology) has been running regularly since its inception in Oxford...
A single blinded RCT comparing triamcinolone with 5-FU treatment for keloid scars
This single blinded RCT compared 43 patients with 50 symptomatic keloids that were randomised to two matched groups of 25 scars, receiving either 5-fluorouracil (5-FU) or current first line treatment, triamcinolone (TAC). The surgeon administering the injectable treatments was unblinded,...New treatment for chronic voice disorders
A new regenerative treatment for people with chronic voice disorders has been used in the UK for the first time. Guy’s and St Thomas’ is the first NHS trust in the country to provide this treatment in the larynx (or voice box) for patients with chronic voice conditions that cause voice change or dysphonia, making the voice sound hoarse, strained, breathy, weak, or fluctuate in pitch and loudness.The role of the respiratory physician in sleep medicine
ENT surgeons may feel that they are the first point of referral for the majority of patients with snoring and possible obstructive sleep apnoea, but in reality a significant number of patients with sleep-disordered breathing (of any cause) are seen...The role of training programmes in protecting patients
ENT trainees are fully registered doctors who have responsibilities to comply with the requirements of Good Medical Practice. This includes ensuring that they put the interests of their patients at the heart of their practice. This duty is complementary to...
Is endoscopic stapes surgery safe and are outcomes comparable to microscopic stapes surgery
Endoscopic techniques for visualisation of the middle ear were described in 1967 by Mer and colleagues, and the use of transcanal endoscopic ear surgery (TEES) has since expanded to a wider range of otologic applications including tympanoplasty and excision of...
